Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
mylan pharmaceuticals pvt ltd
28 Tablet in Bottle
daclatasvir dihydrochloride(60)
Keep in cold place
Delivering To:
Overview
Mydekla 60mg tablet is a prescription-based antiviral medicine. This tablet is used with other medications in the treatment of chronic (long-lasting) Hepatitis C Virus infection in adults. The active ingredient of the Mydekla tablet is Daclatasvir. Daclatasvir is a direct-acting antiviral (DAA) agent that works against Hepatitis C Virus(HCV) and is used for the treatment of chronic HCV genotype 1 and 3 infections.
Hepatitis C
Mydekla 60mg tablet may cause some side effects that vary from one patient to another. Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
Common side effects include:
Fatigue
Headache
Nausea
Insomnia (difficulty in sleeping)
Anemia
Diarrhea
Skin rash
Dizziness
Drowsiness
Unusual tiredness
Vomiting
Contact your doctor immediately if you experience any severe or unusual side effects.
The doctor determines the dosage of Mydekla 60mg tablet as per the patient's health and other medical conditions. Take this medicine at the same time every day as prescribed by your doctor for effective results. It can be taken orally, with or without food. In case of an overdose, contact your doctor immediately.
Alcohol
unsafe
It is advisable not to consume alcohol while taking this medicine.
Pregnancy
consult your doctor
Do not take Mydekla 60mg tablets without consulting your doctor if you are pregnant.
Breast Feeding
consult your doctor
Do not take this medicine while breastfeeding without consulting a doctor.
Driving
danger
It is recommended not to drive or operate heavy machinery, as this medicine may cause side effects that impair your ability to do so.
Kidney
caution
Consult your doctor before taking Mydekla 60mg tablets if you have any kidney problems.
Liver
caution
Inform your doctor about your medical history regarding liver disease before starting treatment with Mydekla 60mg
If you miss a dose, make sure to take it as soon as you remember. Skip the missed dose in case it is already the time for your next scheduled dose. Do not double the dose to catch up.
Mydekla 60mg tablet is an antiviral medicine. This tablet is used with other medications to treat chronic Hepatitis C virus infection in adults.
Store at room temperature (10-30°C). Keep it out of children’s reach. Keep it away from heat, light, and moisture.
If you feel unwell after taking the Mydekla tablet, avoid driving and operating heavy machines.
In kidney disease, Mydekla 60 mg tablet should be administered with caution.
Take it exactly as your healthcare provider tells you. Do not break, crush, or chew the tablet.
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
1. Bunchorntavakul, C., & Reddy, K. R. (2015). The efficacy and safety of daclatasvir in the treatment of chronic hepatitis C virus infection. Alimentary pharmacology & therapeutics, 42(3), 258-272.
2. Montgomery, M., Ho, N., Chung, E., & Marzella, N. (2016). Daclatasvir (Daklinza): a treatment option for chronic hepatitis C infection. Pharmacy and Therapeutics, 41(12), 751.
3. Gandhi, Y., Eley, T., Fura, A., Li, W., Bertz, R. J., & Garimella, T. (2018). Daclatasvir: a review of preclinical and clinical pharmacokinetics. Clinical pharmacokinetics, 57(8), 911-928.
4. Yang, S. S., & Kao, J. H. (2016). Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection. Hepatology international, 10(2), 258-266.
5. Keating, G. M. (2016). Daclatasvir: a review in chronic hepatitis C. Drugs, 76(14), 1381-1391.
mylan pharmaceuticals pvt ltd
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.
Reviewed By
Dr. Aditya Sarin - MBBS, MD, DrNB - Consultant Medical Oncology
Dr. Aditya Sarin, MBBS, MD, DrNB, is a highly qualified medical oncologist with profound research and clinical expertise, currently working at Sir Ganga Ram Hospital, New Delhi. He is also a member of the European Society of Medical Oncology (ESMO), a non-profit European organization dedicated to eradicating cancer by promoting comprehensive cancer care and advancing medical oncology. He has been honored with several awards, including the International Cancer Foundation scholarship (ESMO congress, 2022) and Young Medical Oncologist of the Year (Times of India, 2024). He is well-known for his breakthrough in oncology. Dr. Sarin is passionate about converting complex health information into a concise and clear form that is understandable to everyone, aiming to create awareness and cancer care among people.